Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?

Journal of Endocrinological Investigation

Volumn 24, Issue 2, 2001, Pages 131-134

  Sudhaker Rao, D ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bone density; Hypercalcemia; Nephrolithiasis; Osteitis fibrosa; Osteoporosis; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ALBRIGHT SYNDROME; BONE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE COURSE; FRACTURE; HEALTH CARE MANAGEMENT; HUMAN; HYPERCALCEMIA; KIDNEY FAILURE; MALNUTRITION; NEPHROLITHIASIS; OSTEOPOROSIS; PARATHYROIDECTOMY; PRACTICE GUIDELINE; PRIMARY HYPERPARATHYROIDISM; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY;

EID: 0035095749     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343826     Document Type: Review

References (23)

1. Soaring medical costs and the Mayo "epidemic"
2. Primary hyperparathyroidism: Changing patterns in presentation and treatment decisions in the Eighties
3. Role of vitamin D nutrition in primary hyperparathyroidism: Effect on parathyroid gland mass and on bone
4. Effect of vitamin D nutrition on parathyroid adenoma weight: Pathogenetic and clinical implications
5. Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?
6. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention
7. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: Evidence for biphasic disease course
8. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures
9. Proceedings of the NIH consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism
10. Management of asymptomatic primary hyperparathyroidism
11. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism
12. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
13. Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism
14. Survival and renal function in untreated hypercalcemia: Population-based cohort study with 14 years of follow-up
15. Is parathyroidectomy of benefit in primary hyperparathyroidism?
16. Back pain and vertebral crush fractures: An unemphasized mode of presentation for primary hyperparathyroidism
17. Increased fracture risk in hypercalcemia: Bone mineral content measured in hyperparathyroidism
18. Risk of age-related fractures in patients with primary hyperparathyroidism
19. Primary hyperparathyroidism and the risk of fracture: A population-based study
20. Natural history of untreated mild primary hyperparathyroidism (PHPT): First five year results of a prospective clinical study
21. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism: Final report
22. Cardiovascular effects of parathyroid hormone: A study in healthy subjects and normotensive patients with mild primary hyperparathyroidism
23. Cardiac function and lipid profile in mild asymptomatic primary hyperparathyroidism: Effect in a randomized trial of parathyroidectomy